Press Release: Stoneridge Reports Fourth Quarter and Full-Year 2025 Results

Dow Jones
Mar 12

Outperformed End-Markets by 150 Basis Points in 2025 Driven by MirrorEye$(R)$ Growth of 69%

Drove Improvements in Material Cost of 80 bps and Quality-Related Costs of $6.6 Million in 2025

Issues 2026 Midpoint EBITDA Guidance of $22.5 Million and 2027 EBITDA Target of $44 Million

2025 Fourth Quarter Results

   -- Sales of $205.2 million 
 
   -- Net loss of $(76.9) million ((37.5)% of sales) 
 
          -- Includes the after-tax impairment of Control Devices assets of 
             $(16.7) million and income tax expense related to the recording of 
             valuation allowances of $(44.5) million, net 
   -- Adjusted net loss of $(14.7) million ((7.2)% of sales) 
 
   -- Adjusted EBITDA of $3.4 million (1.7% of sales) 

2026 Full-Year Guidance

   -- Revenue guidance of $625 million - $650 million (midpoint of $638 
      million) represents growth of 4.2% vs. 2025 sales (excluding Control 
      Devices) of $612 million 
 
          -- Guidance conservatively assumes flat end market growth based on 
             current customer expectations (IHS third party production data 
             expects 7.1% year-over-year growth based on our weighted-average 
             OEM end markets) 
 
          -- Expecting continued market outperformance led by MirrorEye growth 
             of at least 45% 
   -- Adjusted EBITDA of $20 million to $25 million (adjusted EBITDA margin of 
      3.2% to 3.8%) 
 
          -- Contribution margin from incremental sales, continued performance 
             improvements and structural cost reductions of $5 million expected 
             to drive significant margin improvement. 

2027 Financial Targets

   -- 2027 revenue target of at least $715 million driven by improving market 
      conditions and continued growth in MirrorEye 
 
          -- Incremental growth opportunities with our aftermarket, off-highway 
             and Brazilian OEM businesses 
   -- 2027 EBITDA expected of at least $44 million based on contribution on 
      incremental revenue 
 
          -- Continued material cost, quality-related cost and structural cost 
             improvement could expand targeted 2027 EBITDA above 
             contribution-based target. 

NOVI, Mich., March 11, 2026 /PRNewswire/ -- Stoneridge, Inc. $(SRI)$ today announced financial results for the fourth quarter ended December 31, 2025.

The Company announced fourth quarter sales of $205.2 million. Gross profit was $33.2 million (16.2% of sales) and adjusted gross profit was $33.2 million (16.2% of sales). Operating loss was $(29.5) million ((14.4)% of sales) while adjusted operating loss was $(6.7) million ((3.3)% of sales). Operating loss was adjusted to account for the pre-tax impairment of Control Devices assets of $(21.6) million among other non-recurring expenses as outlined in Exhibit 2. Net loss was $(76.9) million and adjusted net loss was $(14.7) million. Net loss was adjusted to account for the previously discussed impairment as well as the recording of tax valuation allowances of $44.5 million net, among other non-recurring expenses as outlined in Exhibit 4. Loss per share (EPS) was $(2.76) and adjusted EPS was $(0.53). Adjusted EBITDA was $3.4 million (1.7% of sales).

The Company announced full-year sales of $861.3 million, gross profit of $171.2 million (19.9% of sales) and adjusted gross profit of $173.6 million (20.2% of sales). Operating loss was $(38.6) million ((4.5)% of sales) and adjusted operating loss was $(4.3) million ((0.5)% of sales). Operating loss was adjusted to account for the pre-tax impairment of Control Devices assets of $(21.6) million among other non-recurring expenses as outlined in Exhibit 2. Net loss was $(102.8) million and adjusted net loss was $(31.9) million. Net loss was primarily adjusted to account for the previously discussed asset impairment as well as the recording of tax valuation allowances of $44.5 million net, among other non-recurring expenses as outlined in Exhibit 4. Loss per share was $(3.70) and adjusted EPS was $(1.15). Adjusted EBITDA was $25.0 million (2.9% of sales).

The exhibits attached hereto provide reconciliation details on normalizing adjustments of non-GAAP financial measures used in this press release.

Jim Zizelman, president and chief executive officer, commented, "In 2025, our focused growth strategy, material and quality-related cost improvements, and structural cost control enabled us to navigate another year marked by challenging macroeconomic conditions. Driven by continued momentum with our MirrorEye programs, we outperformed our weighted average end markets by 150 basis points compared to the prior year. MirrorEye sales were $111 million in 2025, which represents 69% growth compared to the prior year, driven by the continued ramp-up of OEM programs in Europe, improved take rates, and two new program launches in North America. Our continued efforts to improve manufacturing performance resulted in an 80-basis point improvement in material costs and an overall reduction in quality-related costs of $6.6 million. We are proud of our ability to continuously outperform our end markets, even in a challenging vehicle production environment, while minimizing the impact on our bottom line. Finally, our focus on reducing inventory, which declined by $18.7 million this year, drove adjusted free cash flow of $19 million."

Zizelman continued, "Earlier this year, we completed the sale of our Control Devices segment. As a result of this sale, we will now focus our resources on our highest growth, highest return businesses and reduce overall organizational complexity leading to a clear, focused strategy for the Company. Natalia Noblet, as the named president and chief executive officer effective April 1st, will continue the strategic vision of the Company, advancing the rigor and discipline we have built over the last several years to drive long-term sustainable performance."

Natalia Noblet, incoming president and chief executive officer, commented, "As president and CEO, my priority will be to continue delivering superior customer value proposition through advanced technology solutions that solve critical challenges and help our customers achieve their long-term goals. Second, my team and I will be focused on excellence in execution to sharpen our strategy and drive financial performance. We will continue to embed rigor and discipline in all our processes to drive operational efficiency and continuous improvement. We are committed to organizational efficiencies to streamline costs to better align our structure with our global goals. Finally, when passion, processes, and priorities are aligned, a strong performance culture emerges -- one that consistently delivers long-term value. As the outcome, we expect to drive market outperformance, margin expansion and cash flow conversion to create value for shareholders, customers and employees."

Noblet continued, "Our advanced product portfolio is directly aligned with industry trends including more automated and connected vehicle technologies, focused on advanced safety and vehicle efficiency. We have built a substantial and growing backlog of awarded programs, and we expect to continue this momentum in the coming years."

Fourth Quarter in Review

Electronics fourth quarter sales of $133.2 million decreased by 10.8%, relative to the fourth quarter of 2024. This was primarily driven by lower commercial vehicle production volumes in Europe and North America, partially offset by incremental MirrorEye sales and favorable foreign exchange translation. Fourth quarter adjusted operating margin of 0.2% decreased by 330 basis points compared to the fourth quarter of 2024, primarily driven by lower contribution on lower sales and higher overhead costs, partially offset by lower D&D due to higher customer reimbursements.

Stoneridge Brazil fourth quarter sales of $16.6 million increased by $4.1 million, or 33.3%, relative to the fourth quarter of 2024. This increase was primarily driven by increased OEM and aftermarket sales. Fourth quarter operating income of $1.3 million increased by approximately $1.2 million compared to the fourth quarter of 2024 primarily due to increased sales and favorable foreign exchange impact on material purchases.

Control Devices fourth quarter sales of $64.4 million increased by 2.0%, relative to the fourth quarter of 2024. This increase was primarily due to higher passenger vehicle sales in North America and China. Fourth quarter adjusted operating margin of (2.3)% improved by 20 basis points compared to the fourth quarter of 2024, primarily driven by lower SG&A and engineering costs.

Full-Year in Review

Electronics full-year sales of $551.4 million decreased by (7.3)% relative to 2024. This decrease was primarily driven by lower customer production volumes in the North American and European commercial vehicle end markets, partially offset by incremental MirrorEye sales driven by the ramp up of a previously launched European OEM program and two additional OEM program launches in North America. Full-year adjusted operating margin of 3.3% decreased by 140 basis points compared to 2024, driven by lower contribution from lower sales and higher overhead costs offset by lower direct material, quality-related and engineering costs.

Stoneridge Brazil full-year sales of $65.1 million increased by 29.9% relative to 2024. This increase was primarily due to OEM sales that almost doubled compared to 2024. Full-year operating margin of 8.6% increased by approximately 660 basis points compared to 2024, primarily driven by increased contribution from incremental sales.

Control Devices full-year sales of $277.9 million decreased by (6.2)% relative to 2024. This decrease was primarily due to the production volume decline in the North American passenger vehicle end market as well as lower sales in the China automotive and off-highway end markets. Full-year adjusted operating margin of 1.6% decreased by 60 basis points compared to 2024, primarily due to lower contribution on lower sales as well as unfavorable mix offset by lower engineering costs.

Cash and Debt Balances

As of December 31, 2025, Stoneridge had cash and cash equivalents totaling $66.3 million and total debt of $180.9 million resulting in net debt of $114.7 million. For the twelve months ending December 31, 2025, the Company generated $34.0 million in net cash provided by operating activities and $19.0 million in adjusted free cash flow.

The Company has entered into an amendment to its current credit facility to extend the maturity date to July 1, 2027 to allow ample time to refinance the existing credit facility and align the long-term capital structure with the structure of the Company after the sale of Control Devices. The Company expects to remain in compliance with all of the amended covenant ratios.

For credit facility compliance purposes, adjusted net debt was $137.7 million while adjusted EBITDA for the trailing twelve months was $39.8 million, resulting in an adjusted net debt to trailing twelve-month EBITDA compliance leverage ratio of 3.46x relative to a required leverage ratio of not greater than 3.75x as per the amended credit facility agreement.

2026 and Future Outlook

The Company is issuing its full-year 2026 sales guidance range of $625 million to $650 million, gross margin guidance of 21.5% to 22.0%, adjusted operating margin guidance of approximately break-even, and adjusted EBITDA guidance of $20 million to $25 million, or approximately 3.2% to 3.8% of sales.

Bob Hartman, chief accounting officer and incoming interim chief financial officer commented, "We are introducing our full-year 2026 guidance ranges, including midpoint revenue of $638 million, representing 4.2% year-over-year growth relative to the 2025 sales for the remaining company. Our revenue guidance assumes that OEM production volumes will remain broadly in line with 2025. That said, based on our weighted average end-markets, IHS is forecasting 7.1% growth in 2026. However, we believe continued geopolitical volatility warrants some level of conservatism. We expect continued strong growth in MirrorEye this year, driven by improved customer take rates and the continued ramp up of recently launched OEM programs, resulting in expected MirrorEye revenue of at least $160 million, or approximately 45% growth. As Natalia outlined previously, we will continue to drive material cost and quality-related improvements as well as reducing our structural costs, which we expect to result in expanded margins. As a result, we expect EBITDA of $20 million to $25 million in 2026."

Noblet continued, "Finally, today we are providing both short-term and long-term revenue and EBITDA targets. Looking at 2027, our weighted-average end markets are expected to grow by 6.6% relative to 2026. In addition, we expect the continued ramp-up and increased customer take rates for our existing MirrorEye OEM programs to drive growth of at least $35 million incremental to 2026. Based on market expectations and MirrorEye-related growth, we are targeting at least $715 million of revenue in 2027. We have additional opportunities to outperform this target, including growth in our aftermarket, off-highway and Brazilian OEM businesses. Based on the contribution margin on expected revenue growth, we are targeting 2027 EBITDA of at least $44 million, or almost double our expected EBITDA in 2026. Incremental to that contribution-based target would be our continued focus on improving material costs, quality-related costs and structural cost reductions to align with our current company structure."

Noblet concluded, "Similarly, we have updated our long-term targets to reflect continued strong growth expectations in our key product categories resulting in a 2030 revenue target of $850 million to $1 billion, implying revenue growth of 2x to 3x our weighted-average end market growth. This results in our expected 2030 EBITDA target of $80 million to $120 million, implying an EBITDA margin range of approximately 9.5% to 12.0%. We remain focused on building a strong foundation for continued earnings expansion as we capitalize on our impressive portfolio of advanced technologies. Stoneridge remains well positioned to continue to outperform our underlying markets and drive margin expansion resulting in long-term shareholder value creation."

Conference Call on the Web

A live Internet broadcast of Stoneridge's conference call regarding 2025 fourth quarter results can be accessed at 9:00 a.m. Eastern Time on Thursday, March 12, 2026, at www.stoneridge.com, which will also offer a webcast replay.

About Stoneridge, Inc.

Stoneridge, Inc., headquartered in Novi, Michigan, is a global supplier of safe and efficient electronic systems and technologies. Our systems and products power vehicle intelligence, while enabling safety and security for on- and off-highway transportation sectors around the world. Additional information about Stoneridge can be found at www.stoneridge.com.

Forward-Looking Statements

Statements in this press release contain "forward-looking statements" under the Private Securities Litigation Reform Act of 1995. These statements appear in a number of places in this press release and may include statements regarding the intent, belief or current expectations of the Company, with respect to, among other things, our (i) future product and facility expansion, (ii) strategic focus following the sale of the Control Devices segment, (iii) acquisition strategy, (iv) investments and new product development, (v) growth opportunities related to awarded business, and (vi) operational expectations. Forward-looking statements may be identified by the words "will," "may," "should," "could," "would," "designed to," "believes," "plans," "projects," "intends," "expects," "estimates," "anticipates," "continue, " and similar words and expressions. The forward-looking statements are subject to risks and uncertainties that could cause actual events or results to differ materially from those expressed in or implied by these statements. Important factors that could cause actual results to differ materially from those in the forward-looking statements include, among other factors:

   -- the ability of our suppliers to supply us with parts and components at 
      competitive prices on a timely basis, including the impact of potential 
      tariffs and trade considerations on their operations and output; 
   -- fluctuations in the cost and availability of key materials and components 
      (including semiconductors, printed circuit boards, resin, aluminum, steel 
      and copper) and our ability to offset cost increases through negotiated 
      price increases with our customers or other cost reduction actions, as 
      necessary; 
   -- global economic trends, competition and geopolitical risks, including 
      impacts from ongoing or potential global conflicts and any related 
      sanctions and other measures, or an escalation of sanctions, tariffs or 
      other trade tensions between the U.S. and other countries; 
   -- tariffs specifically in countries where we have significant direct or 
      indirect manufacturing or supply chain exposure and our ability to either 
      mitigate the impact of tariffs or pass any incremental costs to our 
      customers; 
   -- our ability to achieve cost reductions that offset or exceed 
      customer-mandated selling price reductions; 
   -- the reduced purchases, loss, financial distress or bankruptcy of a major 
      customer or supplier; 
   -- the costs and timing of business realignment, facility closures or 
      similar actions; 
   -- a significant change in commercial, automotive, off-highway or 
      agricultural vehicle production; 
   -- competitive market conditions and resulting effects on sales and pricing; 
   -- foreign currency fluctuations and our ability to manage those impacts; 
   -- customer acceptance of new products; 
   -- our ability to successfully launch/produce products for awarded business; 
   -- adverse changes in laws, government regulations or market conditions 
      affecting our products, our suppliers, or our customers' products; 
   -- our ability to protect our intellectual property and successfully defend 
      against assertions made against us; 
   -- liabilities arising from warranty claims, product recall or field actions, 
      product liability and legal proceedings to which we are or may become a 
      party, or the impact of product recall or field actions on our customers; 
   -- labor disruptions at our facilities, or at any of our significant 
      customers or suppliers; 
   -- business disruptions due to natural disasters or other disasters outside 
      of our control; 
   -- the amount of our indebtedness and the restrictive covenants contained in 
      the agreements governing our indebtedness, including our revolving credit 
      facility; 
   -- capital availability or costs, including changes in interest rates; 
   -- refinancing risk and access to capital markets and liquidity; 
   -- the failure to achieve the successful integration of any acquired company 
      or business; 
   -- risks related to a failure of our information technology systems and 
      networks, and risks associated with current and emerging technology 
      threats and damage from computer viruses, unauthorized access, 
      cyber-attack and other similar disruptions; 
   -- as a result of the sale of the Company's Control Devices business in 
      January 2026, the Company will operate as a two-segment business; the 
      2025 financial statements are not representative of the Company's future 
      operating profile; and 
   -- the items described in Part I, Item 1A ("Risk Factors") in the Company's 
      most recent Form 10-K. 

The forward-looking statements contained herein represent our estimates only as of the date of this filing and should not be relied upon as representing our estimates as of any subsequent date. While we may elect to update these forward-looking statements at some point in the future, except as required by law, we specifically disclaim any obligation to do so, whether to reflect actual results, changes in assumptions, changes in other factors affecting such forward-looking statements or otherwise.

Use of Non-GAAP Financial Information

This press release contains information about the Company's financial results that is not presented in accordance with accounting principles generally accepted in the United States ("GAAP"). Such non-GAAP financial measures are reconciled to their closest GAAP financial measures at the end of this press release. The provision of these non-GAAP financial measures for 2025 and 2024 is not intended to indicate that Stoneridge is explicitly or implicitly providing projections on those non-GAAP financial measures, and actual results for such measures are likely to vary from those presented. The reconciliations include all information reasonably available to the Company at the date of this press release and the adjustments that management can reasonably estimate.

In evaluating its business, the Company considers and uses free cash flow and net debt as supplemental measures of its liquidity and the other non-GAAP financial measures as supplemental measures of its operating performance. Management believes the non-GAAP financial measures used in this press release are useful to both management and investors in their analysis of the Company's financial position and results of operations. In particular, management believes that adjusted sales excluding Control Devices, adjusted gross profit and margin, adjusted operating income (loss) and margin, adjusted income (loss) before tax, adjusted income tax expense (benefit), adjusted net income (loss), adjusted EPS, EBITDA, adjusted EBITDA, adjusted EBITDA excluding Control Devices, adjusted debt, net debt, adjusted net debt, adjusted cash, free cash flow, and adjusted free cash flow are useful measures in assessing the Company's financial performance by excluding certain items that are not indicative of the Company's core operating performance or that may obscure trends useful in evaluating the Company's continuing operating activities. Management also believes that these measures are useful to both management and investors in their analysis of the Company's results of operations and provide improved comparability between fiscal periods.

Sales excluding Control Devices, adjusted gross profit and margin, adjusted operating income (loss) and margin, adjusted income (loss) before tax, adjusted income tax expense (benefit), adjusted net income (loss), adjusted EPS, EBITDA, adjusted EBITDA, adjusted EBITDA excluding Control Devices, adjusted debt, net debt, adjusted net debt, adjusted cash, free cash flow, and adjusted free cash flow should not be considered in isolation or as a substitute for sales, gross profit, operating income (loss), income (loss) before tax, income tax expense (benefit), net income (loss), EPS, debt, cash and cash equivalents, cash provided by operating activities or other income statement or cash flow statement data prepared in accordance with GAAP.

 
CONSOLIDATED BALANCE SHEETS 
 
                                           December 31,       December 31, 
(in thousands)                                     2025               2024 
-----------------------------------   -----------------  ----------------- 
 
ASSETS 
Current assets: 
 Cash and cash equivalents            $          66,252  $          71,832 
 Accounts receivable, less reserves 
  of $383 and $1,060, respectively              131,430            137,766 
 Inventories, net                               132,673            151,337 
 Prepaid expenses and other current 
  assets                                         31,514             26,579 
                                      -----------------  ----------------- 
Total current assets                            361,869            387,514 
                                      -----------------  ----------------- 
Long-term assets: 
 Property, plant and equipment, net              78,922             97,667 
 Intangible assets, net                          37,973             39,677 
 Goodwill                                        37,590             33,085 
 Operating lease right-of-use asset              12,513             10,050 
 Investments and other long-term 
  assets, net                                    22,321             53,563 
Total long-term assets                          189,319            234,042 
                                      -----------------  ----------------- 
Total assets                           $        551,188   $        621,556 
                                      =================  ================= 
 
LIABILITIES AND SHAREHOLDERS' 
EQUITY 
Current liabilities: 
 Accounts payable                     $          82,235  $          83,478 
 Accrued expenses and other current 
  liabilities                                    75,321             66,494 
                                      -----------------  ----------------- 
Total current liabilities                       157,556            149,972 
                                      -----------------  ----------------- 
Long-term liabilities: 
 Revolving credit facility                      180,942            201,577 
 Deferred income taxes                            9,972              5,321 
 Operating lease long-term liability              9,014              6,484 
 Other long-term liabilities                     13,925             12,942 
                                      -----------------  ----------------- 
Total long-term liabilities                     213,853            226,324 
                                      -----------------  ----------------- 
Shareholders' equity: 
 Preferred Shares, without par 
 value, 5,000 shares authorized, 
 none issued                                         --                 -- 
 Common Shares, without par value, 
 60,000 shares authorized, 28,966 
 and 28,966 shares issued and 
 28,018 and 27,695 shares 
 outstanding at December 31, 2025 
 and December 31, 2024, 
 respectively, with no stated 
 value                                               --                 -- 
 Additional paid-in capital                     219,186            225,712 
 Common Shares held in treasury, 948 
  and 1,271 shares at December 31, 
  2025 and December 31, 2024, 
  respectively, at cost                        (27,457)           (38,424) 
 Retained earnings                               77,150            179,985 
 Accumulated other comprehensive 
  loss                                         (89,100)          (122,013) 
                                      -----------------  ----------------- 
Total shareholders' equity                      179,779            245,260 
                                      -----------------  ----------------- 
Total liabilities and shareholders' 
 equity                                $        551,188   $        621,556 
                                      =================  ================= 
 
 
CONSOLIDATED STATEMENTS OF OPERATIONS 
 
Year ended 
December 31, (in 
thousands, except 
per share data)                    2025                 2024                 2023 
-----------------   -------------------  -------------------  ------------------- 
 
Net sales              $        861,263     $        908,295     $        975,818 
Costs and 
expenses: 
 Cost of goods 
  sold                          690,109              719,042              774,512 
 Selling, general 
  and 
  administrative                125,605              117,460              117,395 
 Impairment of 
 Control Devices 
 assets                          21,628                   --                   -- 
 Design and 
  development                    62,527               72,174               71,075 
                    -------------------  -------------------  ------------------- 
Operating (loss) 
 income                        (38,606)                (381)               12,836 
 Interest expense, 
  net                            13,578               14,447               13,000 
 Equity in 
  (earnings) loss 
  of investee                     (340)                1,292                  522 
 Other expense 
  (income), net                   3,608              (2,523)                1,236 
                    -------------------  -------------------  ------------------- 
Loss before income 
 taxes                         (55,452)             (13,597)              (1,922) 
Provision for 
 income taxes                    47,383                2,927                3,261 
                    -------------------  -------------------  ------------------- 
Net loss               $      (102,835)    $        (16,524)   $          (5,183) 
                    ===================  ===================  =================== 
 
Loss per share: 
 Basic              $            (3.70)  $            (0.60)  $            (0.19) 
                    ===================  ===================  =================== 
 Diluted            $            (3.70)  $            (0.60)  $            (0.19) 
                    ===================  ===================  =================== 
 
Weighted-average 
shares 
outstanding: 
 Basic                           27,797               27,596               27,443 
                    ===================  ===================  =================== 
 Diluted                         27,797               27,596               27,443 
                    ===================  ===================  =================== 
 
 
CONSOLIDATED STATEMENTS OF CASH FLOWS 
 Year ended 
 December 31, 
 (in thousands)                       2025                      2024                       2023 
----------------   -----------------------  ------------------------  ------------------------- 
 
OPERATING 
ACTIVITIES: 
Net loss           $             (102,835)  $               (16,524)  $                 (5,183) 
Adjustments to 
reconcile net 
loss to net cash 
provided by 
(used for) 
operating 
activities: 
 Depreciation                       23,731                    26,140                     26,749 
 Amortization, 
  including 
  accretion and 
  write-off of 
  deferred 
  financing 
  costs                              9,955                     8,852                      8,132 
 Deferred income 
  taxes                             37,079                   (5,742)                    (4,038) 
 Impairment of 
 Control Devices 
 assets                             21,628                        --                         -- 
 (Gain) loss of 
  equity method 
  investee                           (340)                     1,292                        522 
 Loss (gain) on 
  sale of fixed 
  assets                               146                       257                      (860) 
 Share-based 
  compensation 
  expense                            4,801                     4,094                      3,322 
 Excess tax 
  deficiency 
  related to 
  share-based 
  compensation 
  expense                              475                       248                        230 
Changes in 
operating assets 
and 
liabilities: 
 Accounts 
  receivable, 
  net                               17,341                    20,170                    (5,854) 
 Inventories, net                   30,765                    26,904                   (31,563) 
 Prepaid expenses 
  and other 
  assets                           (7,489)                       877                     16,625 
 Accounts payable                  (8,780)                  (24,624)                      1,090 
 Accrued expenses 
  and other 
  liabilities                        7,545                     5,804                    (4,226) 
                   -----------------------  ------------------------  ------------------------- 
     Net cash 
      provided by 
      operating 
      activities                    34,022                    47,748                      4,946 
                   -----------------------  ------------------------  ------------------------- 
 
INVESTING 
ACTIVITIES: 
 Capital 
  expenditures, 
  including 
  intangibles                     (21,850)                  (24,303)                   (38,498) 
 Proceeds from 
  sale of fixed 
  assets                               399                       385                      1,869 
 Investment in 
  venture capital 
  fund, net                          (372)                     (550)                      (350) 
                   -----------------------  ------------------------  ------------------------- 
   Net cash used 
    for investing 
    activities                    (21,823)                  (24,468)                   (36,979) 
                   -----------------------  ------------------------  ------------------------- 
 
FINANCING 
ACTIVITIES: 
 Revolving credit 
  facility 
  borrowings                        49,000                   135,500                    117,369 
 Revolving credit 
  facility 
  payments                        (73,191)                 (121,500)                   (96,568) 
 Proceeds from 
  issuance of 
  debt                              19,888                    31,661                     35,757 
Repayments of 
 debt                             (19,882)                  (33,745)                   (35,102) 
 Other financing 
  costs                              (777)                        --                    (2,251) 
Repurchase of 
 Common Shares to 
 satisfy employee 
 tax withholding                     (340)                     (795)                    (1,720) 
                   -----------------------  ------------------------  ------------------------- 
   Net cash (used 
    for) provided 
    by financing 
    activities                    (25,302)                    11,121                     17,485 
                   -----------------------  ------------------------  ------------------------- 
 
 Effect of 
  exchange rate 
  changes on cash 
  and cash 
  equivalents                        7,523                   (3,410)                        591 
                   -----------------------  ------------------------  ------------------------- 
 Net change in 
  cash and cash 
  equivalents                      (5,580)                    30,991                   (13,957) 
 Cash and cash 
  equivalents at 
  beginning of 
  period                            71,832                    40,841                     54,798 
                   -----------------------  ------------------------  ------------------------- 
 
 Cash and cash 
  equivalents at 
  end of period    $                66,252   $                71,832    $                40,841 
                   =======================  ========================  ========================= 
 
 Supplemental 
 disclosure of 
 cash flow 
 information: 
 Cash paid for 
  interest         $                14,166   $                15,458    $                13,007 
 Cash paid for 
  income taxes, 
  net              $                10,337  $                  9,255    $                10,302 
 
 
Regulation G Non-GAAP Financial Measure Reconciliations 
 
Exhibit 1 -- Reconciliation of Adjusted Gross Profit 
------------------------------------------------------------------------------- 
 
  (USD in millions)     Q4 2024         2024         Q4 2025          2025 
                     -------------  ------------  -------------  -------------- 
Gross Profit         $        42.7   $     189.3  $        33.2     $     171.2 
 
Add: Pre-Tax 
 Business 
 Realignment Costs             0.4           0.5            0.1             2.4 
Adjusted Gross 
 Profit              $        43.1   $     189.8  $        33.2     $     173.6 
                     -------------  ------------  -------------  -------------- 
 
Exhibit 2 - Reconciliation of Adjusted Operating Income (Loss) 
------------------------------------------------------------------------------- 
 
(USD in millions)       Q4 2024         2024         Q4 2025          2025 
                     -------------  ------------  -------------  -------------- 
Operating Income 
 (Loss)               $      (4.4)  $      (0.4)    $    (29.5)   $      (38.6) 
 
Add: Pre-Tax 
 Business 
 Realignment Costs             0.4           2.6          (0.1)             6.4 
Add: Pre-Tax 
Environmental 
Remediation Costs               --           0.2             --              -- 
Add: Pre-Tax 
 Strategic Review 
 Costs                          --            --            1.3             6.0 
Add: Pre-Tax 
 Share-Based 
 Compensation 
 Accelerated 
 Vesting                        --            --             --             0.3 
Add: Pre-Tax 
 Impairment of 
 Control Devices 
 Assets                         --            --           21.6            21.6 
Adjusted Operating 
 Income (Loss)        $      (4.0)  $        2.4   $      (6.7)  $        (4.3) 
                     -------------  ------------  -------------  -------------- 
 
 
Exhibit 3 -- Reconciliation of Adjusted Tax Rate 
---------------------------------------------------------------------------- 
 
                Reconciliation of Q4 2025 Adjusted Tax Rate 
---------------------------------------------------------------------------- 
(USD in millions)                                     Q4 2025       Tax Rate 
                                                 -----------------  -------- 
Loss Before Tax                                   $         (31.0) 
 
Add: Pre-Tax Business Realignment Costs                      (0.1) 
Add: Pre-Tax Strategic Review Costs                            1.3 
Add: Pre-Tax Deferred Financing Fee Write Off                  0.2 
Add: Pre-Tax Impairment of Control Devices 
 Assets                                                       21.6 
                                                 ----------------- 
Adjusted Loss Before Tax                         $           (8.0) 
 
Income Tax Expense                                 $          45.9        nm 
 
Add: Tax Impact from Pre-Tax Adjustments                       5.3 
Add: After-Tax Impact of Valuation Allowances, 
 net                                                        (44.5) 
                                                 ----------------- 
Adjusted Income Tax Expense on Adjusted Loss 
 Before Tax                                       $            6.7  (83.3) % 
                                                 ----------------- 
 
 
                Reconciliation of YTD 2025 Adjusted Tax Rate 
(USD in millions)                                      2025         Tax Rate 
                                                 -----------------  -------- 
Loss Before Tax                                   $         (55.5) 
 
Add: Pre-Tax Business Realignment Costs                        6.4 
Add: Pre-Tax Deferred Financing Fee Write Off                  0.2 
Add: Pre-Tax Impairment of Control Devices 
 Assets                                                       21.6 
Add: Pre-Tax Strategic Review Costs                            6.0 
Add: Pre-Tax Share-Based Compensation 
 Accelerated Vesting                                           0.3 
Adjusted Loss Before Tax                          $         (20.9) 
 
Income Tax Expense                                            47.4  (85.4) % 
 
Add: Tax Impact from Pre-Tax Adjustments                       8.1 
Add: After-Tax Impact of Valuation Allowances, 
 net                                                        (44.5) 
                                                 ----------------- 
Adjusted Income Tax Expense                       $           11.0  (52.7) % 
                                                 ----------------- 
 
 
Exhibit 4 - Reconciliation of Adjusted Net Loss and EPS 
---------------------------------------------------------------------------- 
 
           Reconciliation of Q4 2025 Adjusted Net Income and EPS 
---------------------------------------------------------------------------- 
 
  (USD in millions, except EPS)              Q4 2025          Q4 2025 EPS 
                                        -----------------  ----------------- 
Net Loss                                $          (76.9)  $          (2.76) 
 
Add: After-Tax Business Realignment 
Costs                                               (0.1)                 -- 
Add: After-Tax Deferred Financing Fee 
 Write Off                                            0.1               0.01 
Add: After-Tax Strategic Review Costs                 1.0               0.04 
Add: After-Tax Impairment of Control 
 Devices Assets                                      16.7               0.60 
Add: After-Tax Impact of Valuation 
 Allowances, net                                     44.5               1.60 
Adjusted Net Loss                       $          (14.7)  $          (0.53) 
                                        -----------------  ----------------- 
 
 
        Reconciliation of Full-Year 2025 Adjusted Net Income and EPS 
 
  (USD in millions, except EPS)               2025             2025 EPS 
                                        -----------------  ----------------- 
Net Loss                                $         (102.8)  $          (3.70) 
 
Add: After-Tax Business Realignment 
 Costs                                                4.8               0.17 
Add: After-Tax Deferred Financing Fee 
 Write Off                                            0.1               0.01 
Add: After-Tax Share-Based 
 Compensation Accelerated Vesting                     0.2               0.01 
Add: After-Tax Impact of Valuation 
 Allowances, net                                     44.5               1.60 
Add: After-Tax Impairment of Control 
 Devices Assets                                      16.7               0.60 
Add: After-Tax Strategic Review Costs                 4.6               0.17 
Adjusted Net Loss                       $          (31.9)  $          (1.15) 
                                        -----------------  ----------------- 
 
 
Exhibit 5 -- Reconciliation of Adjusted EBITDA 
------------------------------------------------------------------------------------------------------- 
 
(USD in millions)     Q4 2024      2024      Q1 2025     Q2 2025     Q3 2025     Q4 2025       2025 
                     ----------  ---------  ----------  ----------  ----------  ---------  ------------ 
Loss Before Tax      $    (6.2)  $  (13.6)  $    (5.6)  $    (9.1)  $    (9.7)  $  (31.0)   $    (55.5) 
 
Interest expense, 
 net                        3.4       14.4         3.2         3.1         3.8        3.5          13.6 
Depreciation and 
 amortization               8.3       34.3         7.3         7.6         9.5        8.1          32.5 
                     ----------  ---------  ----------  ----------  ----------  ---------  ------------ 
EBITDA                $     5.5  $    35.1   $     4.8   $     1.6   $     3.6  $  (19.4)  $      (9.4) 
                     ----------  ---------  ----------  ----------  ----------  ---------  ------------ 
 
Add: Pre-Tax 
 Business 
 Realignment Costs          0.4        2.6         2.8         1.7         2.1      (0.1)           6.4 
Add: Pre-Tax 
Environmental 
Remediation Costs            --        0.2          --          --          --         --            -- 
Add: Pre-Tax 
 Strategic Review 
 Costs                       --         --          --         1.0         3.7        1.3           6.0 
Add: Pre-Tax 
 Share-Based 
 Compensation 
 Accelerated 
 Vesting                     --         --          --         0.3          --         --           0.3 
Add: Pre-Tax 
 Impairment of 
 Control Devices 
 Assets                      --         --          --          --          --       21.6          21.6 
Adjusted EBITDA       $     6.0  $    37.9   $     7.6   $     4.6   $     9.3  $     3.4    $     25.0 
                     ----------  ---------  ----------  ----------  ----------  ---------  ------------ 
 
 
Exhibit 6 -- Reconciliation of Segment Adjusted Operating Income (Loss) 
------------------------------------------------------------------------------- 
 
      Reconciliation of Control Devices Adjusted Operating Income (Loss) 
------------------------------------------------------------------------------- 
(USD in millions)      Q4 2024         2024          Q4 2025          2025 
                    -------------  -------------  --------------  ------------- 
Control Devices 
 Operating Income 
 (Loss)             $       (1.8)  $         6.2   $      (22.9)   $     (17.9) 
 
Add: Pre-Tax 
Environmental 
Remediation Costs              --            0.2              --             -- 
Add: Pre-Tax 
 Business 
 Realignment 
 Costs                        0.2            0.2           (0.2)            0.7 
Add: Pre-Tax 
 Impairment of 
 Control Devices 
 Assets                        --             --            21.6           21.6 
Control Devices 
 Adjusted 
 Operating Income 
 (Loss)             $       (1.6)  $         6.6  $        (1.5)  $         4.4 
                    -------------  -------------  --------------  ------------- 
 
            Reconciliation of Electronics Adjusted Operating Income 
------------------------------------------------------------------------------- 
(USD in millions)      Q4 2024         2024          Q4 2025          2025 
                    -------------  -------------  --------------  ------------- 
Electronics 
 Operating Income   $         5.1   $       25.6   $         0.2   $       14.3 
 
Add: Pre-Tax 
 Business 
 Realignment 
 Costs                        0.2            2.3             0.1            3.8 
Electronics 
 Adjusted 
 Operating Income   $         5.3   $       27.9   $         0.3   $       18.1 
                    -------------  -------------  --------------  ------------- 
 
 
Exhibit 7 -- Reconciliation of Sales Excluding Control Devices 
---------------------------------------------------------------------------- 
 
(USD in millions)                                               YTD 2025 
                                                             --------------- 
Sales                                                        $     861.3 
 
Less: Control Devices Sales                                  (274.5) 
Add: Inter-segment Sales to Control Devices                  24.7 
                                                             --------------- 
Sales Excluding Control Devices                              $     611.5 
                                                             --------------- 
 
 
Exhibit 8 -- Reconciliation of Adjusted EBITDA Excluding Control Devices 
---------------------------------------------------------------------------- 
 
(USD in millions)                                               YTD 2025 
                                                             --------------- 
Adjusted EBITDA                                                 $       25.0 
 
Less: Control Devices Adjusted EBITDA                                 (10.8) 
Adjusted EBITDA Excluding Control Devices                       $       14.2 
                                                             --------------- 
 
 
Exhibit 9 -- Reconciliation of Adjusted Free Cash Flow 
-------------------------------------------------------------------------------------------------- 
 
(USD in millions)        Q4 2024             YTD 2024            Q4 2025             YTD 2025 
                    ------------------  ------------------  ------------------  ------------------ 
Net Cash Provided 
 by Operating 
 Activities          $            19.2   $            47.7  $              8.8   $            34.0 
 
Capital 
 Expenditures, 
 including 
 Intangibles                     (5.3)              (24.3)               (6.2)              (21.9) 
Proceeds from Sale 
 of Fixed Assets                   0.1                 0.4                 0.1                 0.4 
Free Cash Flow       $            14.1   $            23.8  $              2.7   $            12.6 
                    ------------------  ------------------  ------------------  ------------------ 
 
Business 
 Realignment 
 Related Payments   $              0.4  $              2.6  $              0.1  $              5.7 
Strategic Review 
 Cost Related 
 Payments                          0.0                 0.0                 0.0                 0.7 
Adjusted Free Cash 
 Flow                $            14.5   $            26.4  $              2.8   $            19.0 
                    ------------------  ------------------  ------------------  ------------------ 
 
 
Exhibit 10 -- Reconciliation of Net Debt 
--------------------------------------------------------------------- 
 
                                  December 31,           December 31, 
(USD in millions)                         2024                   2025 
                            ------------------  --------------------- 
Total Debt                   $           201.6   $              180.9 
 
Cash and Cash Equivalents   $             71.8  $                66.3 
Net debt                     $           129.7   $              114.7 
                            ------------------  --------------------- 
 
 
Exhibit 11 -- Reconciliation of Compliance Leverage Ratio 
------------------------------------------------------------------------------------ 
 
            Reconciliation of Adjusted EBITDA for Compliance Calculation 
(USD in millions)            Q1 2025         Q2 2025         Q3 2025         Q4 2025 
                      --------------  --------------  --------------  -------------- 
Loss Before Tax                (5.6)           (9.1)           (9.7)          (31.0) 
Interest Expense, 
 net                             3.2             3.1             3.8             3.5 
Depreciation and 
 Amortization                    7.3             7.6             9.5             8.1 
                      --------------  --------------  --------------  -------------- 
EBITDA                $          4.8  $          1.6  $          3.6  $       (19.4) 
                      --------------  --------------  --------------  -------------- 
 
Compliance 
adjustments: 
Add: Non-Cash 
 Impairment Charges 
 and Write-offs or 
 Write Downs                      --             0.1             0.1            21.7 
Add: Adjustments 
 from Foreign 
 Currency Impact               (0.4)             3.4             2.4           (1.9) 
Add: Extraordinary, 
 Non-recurring or 
 Unusual Items                   0.1              --             0.8             1.2 
Add: Cash 
 Restructuring 
 Charges                         2.8             1.7             2.1           (0.6) 
Add: Charges for 
 Transactions, 
 Amendments, and 
 Refinances                      0.3             1.4             3.7             1.5 
Add: Adjustment to 
 Autotech Fund II 
 Investment                    (0.3)           (0.1)             0.2           (0.2) 
Add: Share Based 
 Compensation                    1.1             1.4             1.1             1.1 
Add: Accrual-based 
 Expenses                        2.2             0.5             1.5             1.6 
Less: Cash Payments 
 for Accrual-based 
 Expenses                      (1.3)              --           (0.1)              -- 
                      --------------  --------------  --------------  -------------- 
Adjusted EBITDA 
 (Compliance)         $          9.4   $        10.0   $        15.4  $          5.1 
                      --------------  --------------  --------------  -------------- 
 
Adjusted TTM EBITDA 
 (Compliance)          $        44.2   $        37.3   $        43.9   $        39.8 
 
 
          Reconciliation of Adjusted Cash for Compliance Calculation 
------------------------------------------------------------------------------ 
(USD in millions)      Q1 2025        Q2 2025        Q3 2025        Q4 2025 
                    -------------  -------------  -------------  ------------- 
Total Cash and 
 Cash Equivalents   $        79.1  $        49.8  $        54.0  $        66.3 
Less: 35% of Cash 
 in Foreign 
 Locations                 (23.3)         (13.4)         (16.4)           20.9 
                    -------------  -------------  -------------  ------------- 
Total Adjusted 
 Cash 
 (Compliance)       $        55.8  $        36.4  $        37.6  $        45.3 
                    -------------  -------------  -------------  ------------- 
 
          Reconciliation of Adjusted Debt for Compliance Calculation 
(USD in millions)      Q1 2025        Q2 2025        Q3 2025        Q4 2025 
                    -------------  -------------  -------------  ------------- 
Total Debt           $      203.2   $      164.4   $      171.1   $      180.9 
Outstanding 
 Letters of 
 Credit                       1.6            1.5            1.5            2.1 
                    -------------  -------------  -------------  ------------- 
Total Adjusted 
 Debt 
 (Compliance)        $      204.8   $      165.9   $      172.6   $      183.0 
                    -------------  -------------  -------------  ------------- 
 
Adjusted Net Debt 
 (Compliance)        $      149.0   $      129.5   $      135.0   $      137.7 
Compliance                  3.37x          3.47x          3.08x          3.46x 
 Leverage Ratio 
 (Net Debt / TTM 
 EBITDA) 
Compliance                  6.00x          5.50x          4.50x          3.75x 
 Leverage Ratio 
 Maximum 
 Requirement 
 

View original content to download multimedia:https://www.prnewswire.com/news-releases/stoneridge-reports-fourth-quarter-and-full-year-2025-results-302711631.html

SOURCE Stoneridge, Inc.

 

(END) Dow Jones Newswires

March 11, 2026 20:05 ET (00:05 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10